C50.51
Malignant neoplasm of lower-outer quadrant of breast, female
Clinical Classification Guidelines
Medical Intelligence & Overview
C50.51 refers to a specific type of breast cancer that occurs in the lower-outer part of the female breast. This area, also known as the lower outer quadrant, is a common site for breast tumors. The term 'malignant neoplasm' indicates that the tumor is cancerous and has the potential to grow and spread if not treated effectively. Recognizing this type of breast cancer early can improve treatment options and outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations inherited from family members Personal or family history of breast cancer Hormonal factors, such as prolonged exposure to estrogen Age, with risk increasing as women age Previous radiation exposure to the chest area Lifestyle factors including alcohol consumption, obesity, and physical inactivity Reproductive history, such as early menstruation or late menopause History of benign breast conditions
Key Symptoms: A lump or thickening in the lower-outer part of the breast Change in the size, shape, or appearance of the breast Skin changes such as redness, dimpling, or puckering Nipple changes including inversion or discharge Persistent pain or tenderness in the affected area Swelling or a lump in the armpit, caused by lymph node involvement Unexplained skin ulcers or persistent skin irritation in the lower outer quadrant
Diagnostic & Treatment
Diagnosis Path: Medical history and physical examination focusing on breast and lymph nodes Imaging tests such as mammography to identify suspicious areas Ultrasound imaging to further evaluate lumps and abnormalities Magnetic resonance imaging (MRI) in certain cases for detailed visualization Biopsy procedures (needle biopsy or surgical biopsy) to confirm the presence of cancer cells Additional tests like hormone receptor and HER2 status assessments to guide treatment options
Treatment Protocols: Surgical procedures such as lumpectomy (removal of the tumor and some surrounding tissue) or mastectomy (removal of the entire breast) Radiation therapy to target residual cancer cells after surgery Chemotherapy to destroy cancer cells throughout the body Hormone therapy for hormone receptor-positive cancers to block estrogen effects Targeted therapy aimed at specific molecules involved in cancer growth Immunotherapy in select cases to boost the body’s immune response against cancer cells Follow-up care including regular screenings and imaging to monitor for recurrence
Clinical Advice & FAQs
Billing Guidance
Is C50.51 a billable ICD-10 code?
Yes, C50.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.51?
Clinical documentation must specify the nature of Malignant neoplasm of lower-outer quadrant of breast, female and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
